Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles matching "sarcoma"

ResearchPUBMEDMar 26

Long-term survival outcomes of female genital tract rhabdomyosarcoma in children, adolescents and young adults at a national rare disease diagnosis and treatment center in China.

Researchers in China studied 26 children and young adults (average age 8 years old) who had a rare cancer called rhabdomyosarcoma that started in the female reproductive organs. They tracked these patients for an average of nearly 5 years to see how well different treatments worked. This study helps doctors understand the best ways to treat this uncommon type of cancer in girls and young women.

WHY IT MATTERSThis is the first large study from China showing long-term survival rates for girls with genital rhabdomyosarcoma, which can help doctors worldwide improve treatment plans and give families more accurate information about what to expect.
💬 Ask your doctorRhabdomyosarcomaFemale genital tract rhabdomyosarcomaGenitourinary rhabdomyosarcomaRead →
ResearchPUBMEDMar 26

[A rare cause of otitis externa : Manifestation of myeloid sarcoma in the petrous bone].

A 45-year-old man had ear canal swelling and an ear infection that wouldn't go away with normal treatment. Doctors performed surgery but didn't find the cause at first. After more testing, they discovered the real problem: cancer cells from a blood disease called acute myeloid leukemia (AML) had come back and were growing in the bone behind his ear.

WHY IT MATTERSThis case shows that persistent ear infections that don't respond to standard treatment could be a sign of leukemia relapse, meaning AML patients with unusual ear symptoms need urgent investigation beyond typical infection treatment.
💬 Ask your doctorAcute Myeloid Leukemia (AML)Myeloid SarcomaOtitis ExternaRead →
ResearchPUBMEDMar 26

Gene Amplification in Rhabdomyosarcoma: Lessons from a Rare Cancer.

Scientists studying a rare childhood cancer called alveolar rhabdomyosarcoma have discovered how cancer cells make extra copies of certain genes that help them grow. They found that different parts of chromosomes (the structures that hold our genes) get copied in different ways—some amplify just one gene, while others amplify multiple genes at once. Understanding these patterns helps doctors figure out which patients might need different treatments.

WHY IT MATTERSThis research identifies specific genetic changes in rhabdomyosarcoma that could lead to targeted treatments tailored to each patient's tumor genetics, potentially improving survival rates for children with this aggressive cancer.
💬 Ask your doctorRhabdomyosarcomaAlveolar RhabdomyosarcomaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases